학술논문
Combined blockade of the IL-13 and IL-33 pathways leads to a greater inhibition of type 2 inflammation over inhibition of either pathway alone
Document Type
Short Communication
Author
Source
In The Journal of Allergy and Clinical Immunology February 2017 139(2):705-708
Subject
Language
ISSN
0091-6749